Latest antiviral News | Page 3

Starpharma wins recognition for development of Covid antiviral nasal spray
Funding boost to home-grown treatment for Covid
COVID vaccines and antiviral medications: update for immunocompromised children and adults with cancer
$31.5 million boost for Covid research
Microscopy reveals mechanism behind new CRISPR tool
New Target Structure Against Corona
Antiviral Effect of Plant Extracts
10 August 2022, Councillor Liesbeth Long- Welcome Record
Apple trees natural response to virus mirrors GM mechanism, study shows
Kids’ noses can better fight Covid
Over 1.65 million doses of Covid vaccines delivered in QLD through community pharmacy
Researchers cook up new recipe for Pretzel-shaped peptides
New campaign to promote Covid oral antiviral treatments
Covid Oral Antiviral Treatments
AMA welcomes new telehealth item but more to be done
Covid modelling update 20 July 2022
Top 3 questions – Living with Covid in winter with Professor Alison McMillan
Elucidation of antiviral/innate immune response activation mechanism of hepatokine LECT2
NSW Government steps up Covid support for vulnerable communities
Expanded Eligibility Criteria for Covid Oral Antiviral Treatments
End of free RAT program puts vulnerable people at risk
Covid oral treatment eligibility expanded from 11 July 2022
Coronavirus update for Victoria 7 July
Expanded eligibility for fourth Covid vaccine dose
ATAGI updated recommendations for winter dose of Covid vaccine
Coronavirus update for Victoria 6 July
Coronavirus update for Victoria 1 July
Coronavirus update for Victoria 30 June
Starpharma’s anti-viral nasal spray relaunched in UK
Coronavirus update for Victoria 29 June
Coronavirus update for Victoria 28 June 2022
Lumos Diagnostics secures authorisation for test in Canada
Coronavirus update for Victoria 26 June 2022
Coronavirus update for Victoria 25 June 2022
WHO publishes updated guidance on hepatitis C infection
Coronavirus update for Victoria 24 June
Don’t pump brakes: our COVID strategy must change to reflect reality
New Way to Identify Influenza Virus Lights Up When Specific Virus Targets are Present
Reducing COVID transmission by 20% could save 2,000 Australian lives this year
PAXLOVID Oral Covid treatment available on Pharmaceutical Benefits Scheme from 1 May
WHO recommends highly successful Covid therapy and calls for wide geographical distribution and transparency from originator
Scientists Develop Indoor-active Photocatalyst for Antiviral Coating Against Various Variant Types of Novel Coronavirus SARS-CoV-2
SARS-CoV-2 virus can infect heart’s pacemaker cells
First Participants dosed in ENA Respiratory’s phase 2a study
Targeting viral lung infections two ways
Elevated inflammation persists in immune cells months after mild Covid
WHO updates its treatment guidelines to include molnupiravir
First Covid pill funded through PBS